Executive Director, Global Established Brands
CurrentGlobal leadership of mature product portfolio of approx $5 billion USD spanning ~30 products in the cardiovascular, gastrointestinal and neuroscience therapeutic areas. Leading cross-functional Global Product Team driving this critical cornerstone of AstraZeneca's business.